Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	245.97	153.3	104.14	585.58	99.96	78.23
Short-Term Investments	207.85	125.28	184.51	70.83	421.71	213.72
Cash & Short-Term Investments	453.81	278.58	288.65	656.41	521.66	291.95
Cash Growth	92.96%	-3.49%	-56.03%	25.83%	78.68%	-23.86%
Accounts Receivable	100.65	105.56	98.4	96.32	53.05	47.53
Other Receivables	0.3	0.4	0.8	0.1	1.6	1.4
Receivables	100.95	105.96	99.2	96.42	54.65	48.93
Inventory	111.87	104.35	96.06	98.55	64.65	58.3
Prepaid Expenses	23.34	20.4	14.32	14.67	10.67	9.38
Other Current Assets	-	0.7	0.1	-	-	-
Total Current Assets	689.97	509.99	498.33	866.05	651.62	408.56
Property, Plant & Equipment	220.68	234.95	254.39	264.81	211.18	142.81
Long-Term Investments	36.73	32.26	60.18	21.99	109.48	74.8
Goodwill	-	163.24	163.24	145.18	99.55	99.55
Other Intangible Assets	440.29	483.26	540.55	623.97	96.52	104.39
Long-Term Deferred Tax Assets	134.02	144.49	160.31	153.36	106.16	-
Other Long-Term Assets	-	6.2	4.2	-	-	0.97
Total Assets	1,522	1,574	1,681	2,075	1,275	831.07
Accounts Payable	19.37	15.7	15.22	10.54	10.43	12.8
Accrued Expenses	76.38	55.72	82.49	118.6	68.78	68.4
Current Portion of Long-Term Debt	201.47	8.64	33.65	374.7	149.65	-
Current Portion of Leases	9.19	8.8	9.12	7.89	7.43	4.94
Current Income Taxes Payable	-	-	-	0.43	0.11	1.33
Other Current Liabilities	-	8.53	7.3	8.95	16.93	20.21
Total Current Liabilities	306.4	97.38	147.77	521.12	253.33	107.67
Long-Term Debt	385.89	513.8	655.82	674.53	313.03	306.05
Long-Term Leases	47.88	54.81	64.8	71.73	71.03	40.94
Other Long-Term Liabilities	31.94	38.27	37.79	77.57	17.44	21.47
Total Liabilities	772.11	704.26	906.19	1,345	654.83	476.12
Common Stock	0.05	0.05	0.05	0.05	0.04	0.04
Additional Paid-In Capital	996.38	976.63	924.1	942.09	873.2	753.98
Retained Earnings	-222.4	-106.8	-148.75	-211.9	-253.88	-399.4
Comprehensive Income & Other	0.68	0.25	-0.38	0.17	0.32	0.32
Shareholders' Equity	749.58	870.13	775.01	730.41	619.69	354.94
Total Liabilities & Equity	1,522	1,574	1,681	2,075	1,275	831.07
Total Debt	644.42	586.04	763.39	1,129	541.13	351.92
Net Cash (Debt)	-190.61	-307.46	-474.74	-472.44	-19.47	-59.97
Net Cash Per Share	-4.12	-5.92	-10.20	-10.35	-0.45	-1.44
Filing Date Shares Outstanding	46.17	46.5	45.95	44.85	43.86	42.03
Total Common Shares Outstanding	46.15	46.48	45.93	44.73	43.64	41.91
Working Capital	383.57	412.61	350.56	344.93	398.3	300.88
Book Value Per Share	16.24	18.72	16.87	16.33	14.20	8.47
Tangible Book Value	309.29	223.63	71.22	-38.74	423.62	151.01
Tangible Book Value Per Share	6.70	4.81	1.55	-0.87	9.71	3.60
Machinery	181.09	141.5	136.46	133.34	89.52	80.9
Construction In Progress	34.53	105.91	103.23	80.56	71.09	38.78
Leasehold Improvements	80.96	61.83	61.3	59.74	54.43	60.44

Source: S&P Capital IQ. Standard template. Financial Sources.